Cite
HARVARD Citation
Hartmann, M. et al. (n.d.). Access to innovative cancer drugs: Divergent outcomes of HTA bodies' appraisals in France, Germany and the United Kingdom impact on the availability of new medicines. European journal of cancer. pp. S115-. [Online].